Document is current
Any future updates will be listed below
-
Authors
Hamza, Yasmeen https://orcid.org/0000-0003-3294-6629
Yang, Ye
Vu, Janie
Abdelmalek, Antoinette
Malekifar, Mobina https://orcid.org/0000-0001-6742-9133
Barnes, Carol A. https://orcid.org/0000-0001-8122-9007
Zeng, Fan-Gang https://orcid.org/0000-0002-4325-2780
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute on Deafness and Other Communication Disorders (R01 DC015587)
- License Information
-
More Information
Article History
Received: 28 May 2024
Accepted: 2 December 2024
First Online: 19 December 2024
Competing interests
: F.G.Z. owns stock in Axonics, Neocortix, Nurotron, Syntiant and Velox Biosystems. The other authors declare no competing interests.
